居家医疗中护士辅助在线眼筛查减少可避免视力损害的健康经济学评价(iScreen):整群随机对照试验研究方案
本研究为在荷兰多家居家医疗机构开展的整群随机对照试验方案,拟招募240名65岁及以上接受居家护理且认知可参与的老年人,比较护士辅助在线眼筛查与常规护理的成本效果与成本效用。筛查包括近远视力及Amsler方格表分级检查,随访至12个月,主要结局为基线至12个月随访时Colenbrander-1M视力表视力变化≥2行。
要点
- 整群随机对照试验将评估居家医疗中护士辅助在线眼筛查相比常规护理的成本效果与成本效用。
- 拟招募240名65岁及以上接受居家护理且认知可参与的老年人,随访基线、6个月和12个月。
- 主要结局为基线至12个月随访时Colenbrander-1M视力表视力变化≥2行。
核心结论
- 针对高危人群的眼筛查有助于发现未诊断和未治疗的视力损害,可能减少视力丧失相关的健康后果及视力损害带来的高经济负担。
研究设计与样本
- 整群随机对照试验,从医疗和社会视角评估居家医疗中在线护士辅助眼筛查相比常规护理的成本效果与成本效用。
- 研究将与荷兰多家居家医疗机构合作开展,共招募240名参与者。
- 纳入标准为65岁及以上、接受居家护理且认知上能够参与的老年男性和女性。
- 在线眼筛查包括近距和远距视力检查,随后进行Amsler方格表分级测试。
- 两组均在基线以及随访6个月和12个月时进行测量。
关键数值与推荐
- 主要结局为基线至12个月随访时Colenbrander-1M视力表视力变化≥2行。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Among older people undiagnosed and untreated vision impairment and blindness are common. The leading causes are uncorrected refractive errors and cataracts. Vision problems are associated with a lower quality of life, several health problems, and a higher chance of falling accidents and fractures. To eliminate avoidable vision impairment and blindness, targeted eye screening programs are recommended. Older patients, receiving home healthcare, have not yet been considered as a population at risk who could benefit from eye screening. METHODS: A cluster-randomized controlled trial will be conducted to investigate the cost-effectiveness and cost-utility of online nurse-assisted eye screening in home healthcare, compared to care as usual, in reducing avoidable vision impairment. A healthcare and societal perspective will be used. The study will be performed in collaboration with several home healthcare organizations in the Netherlands. The online eye screening consists of near and distance visual acuity, followed by an Amsler grading test. Measurements in both groups will take place at baseline and after 6 and 12 months of follow-up. A total of 240 participants will be recruited. Older men and women (65 +), who receive home-based nursing and are cognitively able to participate, will be included. The primary outcome will be the change of two lines or more on the Colenbrander-1 M visual acuity chart between baseline and 12-month follow-up. DISCUSSION: An eye screening for populations at risk contributes to the detection of undiagnosed and untreated vision impairment. This may reduce the health-related consequences of vision loss and the high economic burden associated with vision impairment. TRIAL REGISTRATION: ClinicalTrials.gov NCT06058637. Registered on 27 September 2023.
引用
- Rooth V, van der Aa H, Wisse RPL, et al. Health economic evaluation of a nurse-assisted online eye screening in home healthcare to reduce avoidable vision impairment (iScreen): study protocol for a cluster randomized controlled trial. Trials. 2024. PMID: 38308377. doi:10.1186/s13063-023-07882-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。